Bill Freeman is a member of the Genes and Disease Program at OMRF and a Research Scientist at the OKC Veterans Affairs Medical Center. Dr. Freeman received his BAs in Chemistry and English and PhD in Pharmacology from Wake Forest University. He was then a post-doctoral fellow at the Vollum Institute of Oregon Health Sciences University and Yerkes National Primate Center at Emory University prior to joining the faculty at Penn State University. Dr. Freeman’s lab works on epigenetic and neuroinflammatory mechanisms of brain aging. Recent epigenetic studies by his group have identified non-CpG methylation as the majority of age-related changes in the CNS, described that age-related changes in methylation patterns are sexually divergent in mice and humans, demonstrated that caloric restriction prevents age-related DNA modifications, and developed novel sequencing and analysis tools for DNA modification analysis.
Willard Freeman PhD
Bill Freeman is a member of the Genes and Disease Program at OMRF and a Research Scientist at the OKC Veterans Affairs Medical Center. Dr. Freeman received his BAs in Chemistry and English and PhD in Pharmacology from Wake Forest University. He was then a post-doctoral fellow at the Vollum Institute of Oregon Health Sciences University and Yerkes National Primate Center at Emory University prior to joining the faculty at Penn State University. Dr. Freeman’s lab works on epigenetic and neuroinflammatory mechanisms of brain aging. Recent epigenetic studies by his group have identified non-CpG methylation as the majority of age-related changes in the CNS, described that age-related changes in methylation patterns are sexually divergent in mice and humans, demonstrated that caloric restriction prevents age-related DNA modifications, and developed novel sequencing and analysis tools for DNA modification analysis.
